TG Therapeutics

ISIN US88322Q1085

 | 

WKN A1JXW7

Market cap (in EUR)
7,121 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 7,121 m
EPS, EUR 2.35
P/B ratio 14.2
P/E ratio 20.4
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 546 m
Net income, EUR 396 m
Profit margin 72.56%

What ETF is TG Therapeutics in?

There are 7 ETFs which contain TG Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of TG Therapeutics is the iShares S&P SmallCap 600 UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares S&P SmallCap 600 UCITS ETF 0.39%
Equity
United States
Small Cap
2,730
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
552
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist 0.24%
Equity
United States
Small Cap
3
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
28
WisdomTree Russell 2000 0.25%
Equity
United States
Small Cap
7
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.10%
Equity
United States
Small Cap
226
Vanguard FTSE Global All-Cap UCITS ETF USD Dist 0.01%
Equity
World
9
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.